UCI Therapeutics - Crunchbase Company Profile & Funding

Q: Who invested in UCI Therapeutics?

UCI Therapeutics has 7 investors including Pathfinder H And Smilegate Investment.

Q: When was the last funding round for UCI Therapeutics?

UCI Therapeutics closed its last funding round on obfuscated from a Seed round.

Q: How much funding has UCI Therapeutics raised to date?

UCI Therapeutics has raised obfuscated.

Overview

UCI Therapeutics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Events

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About UCI Therapeutics

CB Rank

161536

UCI Therapeutics is a biopharmaceutical company.

Founded

obfuscation

Private

Seed

Pohang, Kyongsang-bukto, South Korea

1-10

www.uci-therapeutics.co.kr

Biotechnology

Product Research

Therapeutics

Funding Rounds

Seed

OBF

obfuscation

Seed

OBF

obfuscation

Details

Legal Name

UCI Therapeutics Inc.

Also Known As

유씨아이테라퓨틱스

Operating Status

Active

Company Type

For Profit

Phone Number

+82 026 466 3636

Contact Email

contact@uci-therapeutics.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

CAR-NK Immunotherapy

A cell-based immunotherapy using genetically engineered natural killer (NK) cells with chimeric antigen receptors (CAR) to target and treat solid tumors.

CellTaCT Platform

A platform technology for developing cell-based fusion therapies combining cell therapy and anticancer drugs to enhance treatment effects against solid tumors.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Seed Round - UCI Therapeutics	6	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - UCI Therapeutics	6	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - UCI Therapeutics	6	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - UCI Therapeutics	6	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - UCI Therapeutics	6	obfuscated obfuscation	—	Seed

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Seed Round - UCI Therapeutics	6	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - UCI Therapeutics	6	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - UCI Therapeutics	6	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - UCI Therapeutics	6	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - UCI Therapeutics	6	obfuscated obfuscation	—	Seed

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Pathfinder H	—	Seed Round - UCI Therapeutics	—
Pathfinder H	—	Seed Round - UCI Therapeutics	—
Pathfinder H	—	Seed Round - UCI Therapeutics	—
Pathfinder H	—	Seed Round - UCI Therapeutics	—
Pathfinder H	—	Seed Round - UCI Therapeutics	—